Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07890675Recruiting

Danang Cerebral Venous Thrombosis Registry

Role: lead

NCT07702552Not ApplicableNot Yet Recruiting

Postoperative Analgesic Efficacy of ACB+iPACK vs FTB+Selective Tibial+Obturator Blocks in ACL Reconstruction

Role: lead

NCT02923817Phase 2Unknown

Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury

Role: lead

All 3 trials loaded